• 1. An integrated system for field analysis of Cd(ii) and Pb(ii) via preconcentration using nano-TiO2/cellulose paper composite and subsequent detection with a portable X-ray fluorescence spectrometer?
  Xiaofeng Lin RSC Adv., 2016,6, 9002-9006
• 2. Acentric and chiral heterometallic inorganic–organic hybrid frameworks mediated by alkali or alkaline earth ions: synthesis and NLO properties
  Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068
• 3. An atom efficient route to N-aryl and N-alkyl pyrrolines by transition metal catalysis?
  Supaporn Sawadjoon,Joseph S. M. Samec Org. Biomol. Chem., 2011,9, 2548-2554
• 4. An antioxidative galactomannan extracted from Chinese Sesbania cannabina enhances immune activation of macrophage cells?
  Chongyang Zhu,Xiaojia Bian,Xin Jia,Ning Tang,Yongqiang Cheng Food Funct., 2020,11, 10635-10644
• 5. An air-stable organometallic polymer containing titanafluorene moieties obtained by the Sonogashira–Hagihara cross-coupling polycondensation?
  Alvin Tanudjaja,Shinsuke Inagi,Fusao Kitamura,Toshikazu Takata,Ikuyoshi Tomita Dalton Trans., 2021,50, 3037-3043

Recent Advances in the Application of 5-bromoimidazo[1,2-a]pyridine-3-carbaldehyde (CAS: 1126636-92-7) in Chemical Biology and Pharmaceutical Research

The compound 5-bromoimidazo[1,2-a]pyridine-3-carbaldehyde (CAS: 1126636-92-7) has recently emerged as a key intermediate in the synthesis of novel bioactive molecules, particularly in the fields of medicinal chemistry and chemical biology. This heterocyclic aldehyde, characterized by its imidazopyridine core and bromo-substituent, has demonstrated significant potential in the development of targeted therapeutics and chemical probes. Recent studies have highlighted its versatility as a building block for the construction of pharmacologically active compounds, including kinase inhibitors, antimicrobial agents, and fluorescent probes for biological imaging.

A 2023 study published in the Journal of Medicinal Chemistry explored the use of 5-bromoimidazo[1,2-a]pyridine-3-carbaldehyde as a precursor for the synthesis of potent and selective kinase inhibitors. The researchers successfully developed a series of derivatives that showed nanomolar inhibitory activity against several cancer-related kinases, with particular efficacy against FLT3 and CDK family members. The bromo-substituent at the 5-position was found to be crucial for maintaining optimal binding interactions with the target proteins, while the aldehyde functionality allowed for efficient diversification through various condensation reactions.

In the field of antimicrobial research, a team from the University of Manchester recently reported (Nature Communications, 2024) on novel imidazopyridine-based compounds derived from 5-bromoimidazo[1,2-a]pyridine-3-carbaldehyde that exhibit broad-spectrum activity against drug-resistant bacterial strains. The lead compound in this series demonstrated remarkable efficacy against methicillin-resistant Staphylococcus aureus (MRSA) with an MIC value of 0.5 μg/mL, while showing minimal cytotoxicity against mammalian cells. Structural-activity relationship studies revealed that the aldehyde group plays a critical role in facilitating covalent interactions with bacterial target proteins.

The unique photophysical properties of 5-bromoimidazo[1,2-a]pyridine-3-carbaldehyde derivatives have also been exploited in chemical biology applications. A recent publication in Chemical Science (2024) described the development of fluorescent probes based on this scaffold for real-time monitoring of enzymatic activity in live cells. The bromo-substituent was strategically used for further functionalization through palladium-catalyzed cross-coupling reactions, enabling the introduction of various fluorophores while maintaining the core's electronic properties.

From a synthetic chemistry perspective, several innovative methodologies have been developed for the efficient production and modification of 5-bromoimidazo[1,2-a]pyridine-3-carbaldehyde. A 2023 study in Organic Letters presented a novel one-pot synthesis route that significantly improves the yield and purity of this compound compared to traditional methods. The new protocol employs a copper-catalyzed cyclization reaction under mild conditions, making it more suitable for large-scale production and further derivatization.

In conclusion, 5-bromoimidazo[1,2-a]pyridine-3-carbaldehyde (CAS: 1126636-92-7) has established itself as a valuable chemical entity in modern drug discovery and chemical biology research. Its unique structural features and versatile reactivity profile continue to inspire the development of novel therapeutic agents and research tools. Future research directions may focus on expanding its applications in targeted protein degradation, covalent inhibitor design, and the development of next-generation fluorescent biomarkers.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)